Providers report that despite vendor efforts, clinical decision support (CDS) reference products are still not integrated enough to deliver the strategic direction providers are looking for.

Medtronic, corevalve, edwards, litigation, TAVR, TAVI

In a move that calls into question the future of transcatheter valve competition in the United States, a jury in the Federal District Court of Delaware decided Jan. 15 the Medtronic CoreValve infringes on transcatheter device patents held by Edwards Lifesciences Corp. Medtronic said it intends to appeal the decision.

A new “fluid biopsy” technique that could identify patients at high risk of a heart attack by identifying specific cells as markers in the bloodstream has been developed by a group of researchers at The Scripps Research Institute (TSRI).

mri systems clinical trial study university pennsylvania creatine CEST map

A new magnetic resonance imaging (MRI) method to map creatine at higher resolutions in the heart may help clinicians and scientists find abnormalities and disorders earlier than traditional diagnostic methods.
cath lab stents bioresorbable amaranth fortitude scaffold

Amaranth Medical announced the closing of an equity investment by Boston Scientific Corp.
heart valve repair clinical trial study edwards lifesciences sapien 3

Edwards Lifesciences Corp. announced that it received investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to initiate a clinical trial of the Sapien 3 transcatheter aortic heart valve in the treatment of intermediate risk patients with severe symptomatic aortic stenosis.

 MediValve Ltd. announced that it has received clearance of a Pre-Marketing Notification Application (510(k)) from the U.S. Food and Drug Administration (FDA) for its acWire Guidewire.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now